{"id":"NCT01807949","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation","officialTitle":"A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2013-03-08","resultsPosted":"2015-09-01","lastUpdate":"2016-09-27"},"enrollment":563,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis, Homozygous for the F508del CFTR Mutation"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Lumacaftor Plus Ivacaftor Combination","otherNames":["VX-809+VX-770, LUM+IVA"]},{"type":"DRUG","name":"Ivacaftor","otherNames":["VX-770, IVA"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"LUM 600 mg qd/IVA 250 mg q12h","type":"EXPERIMENTAL"},{"label":"LUM 400 mg q12h/ IVA 250 mg q12h","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to evaluate the efficacy of lumacaftor in combination with ivacaftor at Week 24 in participants aged 12 years and older with cystic fibrosis (CF) who are homozygous for the F508del mutation on the CF transmembrane conductance regulator (CFTR) gene.","primaryOutcome":{"measure":"Absolute Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) at Week 24","timeFrame":"Baseline, Week 16 and 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.15,"sd":0.539},{"arm":"LUM 600 mg qd/IVA 250 mg q12h","deltaMin":2.46,"sd":0.54},{"arm":"LUM 400 mg q12h/ IVA 250 mg q12h","deltaMin":2.85,"sd":0.54}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0004"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":82,"countries":["United States","Australia","Austria","Belgium","Canada","Denmark","France","Germany","Spain","United Kingdom"]},"refs":{"pmids":["37983082","36509366","33331662","30587335","30146268","27298017","25981758"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":57,"n":186},"commonTop":["Cough","Infective pulmonary exacerbation of cystic fibrosis","Sputum increased","Headache","Dyspnoea"]}}